Nicholas Keen - Oct 1, 2021 Form 4 Insider Report for BICYCLE THERAPEUTICS plc (BCYC)

Role: Chief Scientific Officer
Signature: /s/ Lee Kalowski, Attorney-in-Fact
Stock symbol: BCYC
Transactions as of: Oct 1, 2021
Transactions value $: -$151,688
Form type: 4
Date filed: 10/5/2021, 04:16 PM
Previous filing: Sep 17, 2021
Next filing: Dec 22, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCYC	Ordinary Shares	Sale	-$53.5K	-1.19K	-35.29%	$45.00	2.18K	Oct 1, 2021	Direct	F1
transaction	BCYC	Ordinary Shares	Sale	-$98.2K	-2.18K	-100%	$45.10	0	Oct 5, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were sold pursuant to a Rule 10b5-1 trading plan.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.52 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Shares were sold pursuant to a Rule 10b5-1 trading plan.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.52 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.